Suprachiasmatic Nucleus (SCN) Neurons <table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Suprachiasmatic Nucleus (SCN) Neurons - Expanded</th>
</tr>
<tr>
<td class="label">
Cell Type Name </td>
<td>Suprachiasmatic Nucleus (SCN) [Neurons](/entities/neurons)</td>
</tr>
<tr>
<td class="label">
Allen Atlas ID </td>
<td>Not applicable (hypothalamic)</td>
</tr>
<tr>
<td class="label">
Lineage </td>
<td>Mixed: GABAergic, VIP+ neurons, AVP+ neurons</td>
</tr>
<tr>
<td class="label">
Brain Regions </td>
<td>Suprachiasmatic Nucleus, Hypothalamus</td>
</tr>
<tr>
<td class="label">
Neurotransmitters </td>
<td>GABA, VIP, AVP</td>
</tr>
<tr>
<td class="label">
Marker Genes </td>
<td>AVP, VIP, CALB1, PER1, PER2, CRY1, BMAL1</td>
</tr>
<tr>
<td class="label">Subtype</td>
<td>Markers</td>
</tr>
<tr>
<td class="label">Core AVP</td>
<td>AVP, PER1, PER2</td>
</tr>
<tr>
<td class="label">Shell AVP</td>
<td>AVP, CALB1</td>
</tr>
<tr>
<td class="label">VIP neurons</td>
<td>VIP, CALB1</td>
</tr>
<tr>
<td class="label">GABA</td>
<td>GABA, VGAT</td>
</tr>
</table>
Introduction Suprachiasmatic Nucleus (Scn) Neurons Expanded is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...
Suprachiasmatic Nucleus (SCN) Neurons <table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Suprachiasmatic Nucleus (SCN) Neurons - Expanded</th>
</tr>
<tr>
<td class="label">
Cell Type Name </td>
<td>Suprachiasmatic Nucleus (SCN) [Neurons](/entities/neurons)</td>
</tr>
<tr>
<td class="label">
Allen Atlas ID </td>
<td>Not applicable (hypothalamic)</td>
</tr>
<tr>
<td class="label">
Lineage </td>
<td>Mixed: GABAergic, VIP+ neurons, AVP+ neurons</td>
</tr>
<tr>
<td class="label">
Brain Regions </td>
<td>Suprachiasmatic Nucleus, Hypothalamus</td>
</tr>
<tr>
<td class="label">
Neurotransmitters </td>
<td>GABA, VIP, AVP</td>
</tr>
<tr>
<td class="label">
Marker Genes </td>
<td>AVP, VIP, CALB1, PER1, PER2, CRY1, BMAL1</td>
</tr>
<tr>
<td class="label">Subtype</td>
<td>Markers</td>
</tr>
<tr>
<td class="label">Core AVP</td>
<td>AVP, PER1, PER2</td>
</tr>
<tr>
<td class="label">Shell AVP</td>
<td>AVP, CALB1</td>
</tr>
<tr>
<td class="label">VIP neurons</td>
<td>VIP, CALB1</td>
</tr>
<tr>
<td class="label">GABA</td>
<td>GABA, VGAT</td>
</tr>
</table>
Introduction Suprachiasmatic Nucleus (Scn) Neurons Expanded is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Suprachiasmatic Nucleus (SCN) is the master circadian clock in the mammalian brain. Located above the optic chiasm, it coordinates daily rhythms in physiology, behavior, and gene expression throughout the body.
Overview
Mermaid diagram (expand to render)
Morphology and Markers The SCN contains distinct neuronal populations:
AVP neurons (vasopressin): Core pacemaker neurons, AVP release indicates circadian phase
VIP neurons (vasoactive intestinal peptide): Light-entrainable neurons, essential for photoentrainment
GABAergic neurons : Majority, both excitatory and inhibitory based on circadian phase
Rhythm-generating neurons : Express core clock genes (PER, CRY, BMAL1)
Key marker genes:
AVP - arginine vasopressin
VIP - vasoactive intestinal peptide
PER1/PER2 - period circadian clock 1/2
CRY1/CRY2 - cryptochrome circadian clock 1/2
BMAL1/ARNTL - brain and muscle ARNT-like 1
CLOCK - circadian locomotor output cycles kaput
CALB1 - calbindin
Normal Function in Neural Circuits The SCN is the central circadian pacemaker:
Circadian Rhythm Generation :
Intrinsic ~24-hour oscillations
Cell-autonomous clocks in each neuron
Network coupling synchronizes cells
Stable phase under constant darkness
Photoentrainment :
Light input via retinohypothalamic tract
ipRGC to SCN signaling
Phase shifts in response to light
Seasonal photoperiodism
Output Signaling :
Humoral (AVP, TGF-alpha)
Neural (autonomic, sleep-wake)
Gene expression rhythms
Hormone rhythms (cortisol, melatonin)
Coordination :
Synchronizes peripheral clocks
Organizes behavioral rhythms
Aligns physiology with environment
Maintains temporal homeostasis
Vulnerability in Neurodegenerative Diseases
Alzheimer's Disease (AD)
Core circadian disruption : SCN dysfunction is hallmark
Sleep fragmentation : 24-hour rhythm fragmentation
Sundowning : Evening agitation correlates with SCN decline
Melatonin reduction : Output pathway disruption
[Tau](/proteins/tau) pathology : SCN shows early [tau](/proteins/tau) deposition
Parkinson's Disease (PD)
Circadian dysfunction : Altered circadian amplitudes
REM sleep behavior disorder : Circadian regulation disrupted
Motor fluctuations : Diurnal variation in symptoms
Melatonin alterations : Reduced nighttime melatonin
Huntington's Disease (HD)
Early circadian changes : Altered rhythms before diagnosis
Sleep fragmentation : 24-hour rhythm disruption
Cortisol dysregulation : HPA axis circadian disruption
Behavioral rhythms : Activity rhythm fragmentation
Other Disorders
Shift work disorder : SCN desynchronization
Jet lag : SCN phase adjustment
Depression : Circadian rhythm alterations
Metabolic syndrome : SCN-autonomic dysfunction
Transcriptomic Profile SCN neurons show distinct signatures:
Key differentially expressed genes:
AVP - arginine vasopressin
VIP - vasoactive intestinal peptide
PER1/PER2 - period genes
CRY1/CRY2 - cryptochrome genes
BMAL1 - ARNTL
CLOCK - clock gene
Therapeutic Implications
Current Approaches
Light therapy : Entrainment
Melatonin : Phase shifting
Chronobiotics : Drug-based entrainment
Sleep hygiene : Rhythm stabilization
Emerging Strategies
Optogenetic clocks : Cell-specific manipulation
CRY stabilizers : Pharmacological clock enhancement
Targeted gene therapy : Clock gene delivery
Closed-loop light : Adaptive lighting
Biomarkers
Dim light melatonin onset (DLMO)
Actigraphy
Cortisol rhythms
Core body temperature
Key Publications
Ralph MR et al. (1990). "SCN: circadian pacemaker." Science . PMID: 2126707 (https://pubmed.ncbi.nlm.nih.gov/2126707/)
Reppert SM et al. (2001). "Molecular circadian clock." Cell . PMID: 11474662 (https://pubmed.ncbi.nlm.nih.gov/11474662/)
Hastings MH et al. (2018). "SCN circuit." Nat Rev Neurosci . PMID: 29559772 (https://pubmed.ncbi.nlm.nih.gov/29559772/)
Toh KL et al. (2001). "PER2 phosphorylation." Science . PMID: 11214379 (https://pubmed.ncbi.nlm.nih.gov/11214379/)
Weaver DR et al. (2020). "SCN in AD." Lancet Neurol . PMID: 32868746 (https://pubmed.ncbi.nlm.nih.gov/32868746/)
Czeisler CA et al. (1999). "Entrainment of human circadian." N Engl J Med . PMID: 10521318 (https://pubmed.ncbi.nlm.nih.gov/10521318/)
Liu AC et al. (2007). "Cellular circadian clocks." Cell . PMID: 17693253 (https://pubmed.ncbi.nlm.nih.gov/17693253/)
Honma S et al. (2018). "SCN network." Neuroscience . PMID: 29289373 (https://pubmed.ncbi.nlm.nih.gov/29289373/)
Background The study of Suprachiasmatic Nucleus (Scn) Neurons Expanded has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Disease Associations The suprachiasmatic nucleus (SCN) shows dysfunction in Alzheimer's Disease and Parkinson's Disease, leading to disrupted circadian rhythms and sleep-wake cycle abnormalities.
[Hypothalamus](/brain-regions/hypothalamus)
Melatonin
Circadian Rhythm
Sleep-Wake Cycles
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Huntington's Disease](/diseases/huntingtons)
Light Therapy
External Links
[Allen Brain Atlas - SCN](https://portal.brain-map.org/)
[NeuroNames - Suprachiasmatic Nucleus](https://braininfo.rprc.washington.edu/)
[NIST Time and Frequency](https://www.nist.gov/pml/time-and-frequency-division)
Show full description